SEC-sourced researchBeta
FHTX
Foghorn Therapeutics Inc.
Company comparison ↗
Data passport
- CIK
- 0001822462
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 22,602,000.0000 | Mar 11, 2026 |
| December 2025 | 30,909,000.0000 | Mar 11, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 30,909,000.0000 | -74,283,000.0000 | -86,099,000.0000 | 198,103,000.0000 | 306,603,000.0000 | Mar 11, 2026 |
| December 2024 | 22,602,000.0000 | -86,620,000.0000 | -100,406,000.0000 | 283,982,000.0000 | 329,510,000.0000 | Mar 11, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $30.91M | December 2025 | Mar 11, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $22.6M | December 2024 | Mar 11, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$74.28M | December 2025 | Mar 11, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$86.1M | December 2025 | Mar 11, 2026 | 10-K |
| Total assetsAssets | $198.1M | December 2025 | Mar 11, 2026 | 10-K |
| Total liabilitiesLiabilities | $306.6M | December 2025 | Mar 11, 2026 | 10-K |